As of January 2025 Biohaven Pharmaceutical has a market cap of โฌ3.84 Billion. This makes Biohaven Pharmaceutical the world's 3075th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โฌ3.84 B | 7.85% |
2024 | โฌ3.56 B | 14.68% |
2023 | โฌ3.10 B | 252.21% |
2022 | โฌ0.88 B | -88.93% |
2021 | โฌ7.97 B | 90.83% |
2020 | โฌ4.17 B | 64.07% |
2019 | โฌ2.54 B | 78.19% |
2018 | โฌ1.42 B | 76.41% |
2017 | โฌ0.80 B |
On Jan 8th, 2025 the market cap of Biohaven Pharmaceutical was reported to be: